Pfizer reported Q2 FY 2016 earnings of $0.64 per share (versus $0.56 in Q2 FY 2015), beating analysts' consensus estimate of $0.62.
The company's quarterly revenues amounted to $13.147 bln (+10.9% y/y), beating analysts' consensus estimate of $13.013 bln.
PFE rose to $37.60 (+0.78%) in pre-market trading.